US Stock MarketDetailed Quotes
NRXP NRX Pharmaceuticals
- 1.3200
- -0.0650-4.69%
Close Nov 4 16:00 ET
- 1.3000
- -0.0200-1.52%
Post 18:29 ET
14.19MMarket Cap-492P/E (TTM)
1.4400High1.3100Low179.20KVolume1.3800Open1.3850Pre Close246.09KTurnover2.27%Turnover RatioLossP/E (Static)10.75MShares7.333052wk High-0.77P/B10.43MFloat Cap1.100052wk Low--Dividend TTM7.90MShs Float769.9000Historical High--Div YieldTTM9.39%Amplitude1.1000Historical Low1.3730Avg Price1Lot Size
NRX Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 67.20%-2.56M | 39.71%-3.67M | 45.52%-21.66M | 61.63%-3.19M | 27.16%-4.56M | 47.18%-7.81M | 41.34%-6.09M | -5.44%-39.76M | 26.26%-8.32M | 47.84%-6.27M |
| Net income from continuing operations | 9.41%-7.9M | 40.86%-6.53M | 24.16%-30.15M | 57.70%-4.33M | 33.26%-6.06M | -24.85%-8.72M | 17.91%-11.04M | 57.28%-39.75M | 66.32%-10.24M | 75.48%-9.08M |
| Operating gains losses | -263.64%-18K | 175.00%9K | 92.16%-20K | 136.84%7K | -170.27%-26K | 109.48%11K | 92.36%-12K | 85.93%-255K | 97.81%-19K | -99.78%37K |
| Depreciation and amortization | 0.00%1K | 0.00%1K | 25.00%5K | 0.00%1K | 100.00%2K | 0.00%1K | 0.00%1K | 100.00%4K | --1K | 0.00%1K |
| Other non cash items | 141.84%2.21M | -82.05%318K | 172.53%2.96M | -117.23%-87K | --359K | 136.80%913K | 184.34%1.77M | -107.51%-4.08M | -97.39%505K | --0 |
| Change In working capital | 640.25%3.05M | -8.30%2.29M | 638.77%5.16M | 261.49%2.42M | -63.72%812K | 90.90%-564K | -37.51%2.49M | 114.27%699K | 171.43%670K | 259.86%2.24M |
| -Change in prepaid assets | -308.35%-898K | -49.08%250K | 581.01%3.04M | 83.23%1.49M | -51.90%632K | 109.61%431K | -71.57%491K | 86.86%-632K | -34.65%811K | 209.41%1.31M |
| -Change in payables and accrued expense | 496.48%3.95M | 1.70%2.04M | 59.58%2.12M | 763.83%936K | -80.52%180K | 42.02%-995K | -11.53%2M | 244.67%1.33M | 93.53%-141K | 564.32%924K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 67.20%-2.56M | 39.71%-3.67M | 45.52%-21.66M | 61.63%-3.19M | 27.16%-4.56M | 47.18%-7.81M | 41.34%-6.09M | -5.44%-39.76M | 26.26%-8.32M | 47.84%-6.27M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 70.00%-3K | 0.00%1K | 60.00%-2K | 166.67%2K | -33.33%-4K | -42.86%-10K | 1K | -25.00%-5K |
| Net PPE purchase and sale | --0 | --0 | 70.00%-3K | 0.00%1K | 60.00%-2K | 166.67%2K | -33.33%-4K | -42.86%-10K | --1K | -25.00%-5K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | 70.00%-3K | 0.00%1K | 60.00%-2K | 166.67%2K | -33.33%-4K | -42.86%-10K | --1K | -25.00%-5K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -49.93%3.14M | -84.48%395K | -80.75%6.2M | -111.03%-1.12M | -5,260.71%-1.5M | 829.42%6.27M | -88.93%2.55M | -49.23%32.21M | 1,012,100.00%10.12M | -100.07%-28K |
| Net issuance payments of debt | -100.14%-1K | ---2.16M | -132.54%-3.09M | -111.14%-1.12M | ---2.67M | --696K | --0 | 844.67%9.5M | 1,001,900.00%10.02M | --0 |
| Net common stock issuance | -43.66%3.14M | 0.20%2.55M | -64.22%8.12M | --0 | --0 | 1,730.70%5.58M | -88.93%2.55M | -38.62%22.7M | --92K | -100.10%-28K |
| Net preferred stock issuance | ---- | ---- | --1.17M | --0 | ---- | ---- | ---- | --0 | --0 | ---- |
| Proceeds from stock option exercised by employees | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -99.94%10K | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -49.93%3.14M | -84.48%395K | -80.75%6.2M | -111.03%-1.12M | -5,260.71%-1.5M | 829.42%6.27M | -88.93%2.55M | -49.23%32.21M | 1,012,100.00%10.12M | -100.07%-28K |
| Net cash flow | ||||||||||
| Beginning cash position | -92.01%1.32M | -77.09%4.6M | -27.35%20.05M | -51.22%8.9M | -39.02%14.97M | -58.94%16.51M | -27.35%20.05M | 1,384.94%27.61M | -53.07%18.25M | 83.39%24.55M |
| Current changes in cash | 137.67%579K | 7.67%-3.28M | -104.73%-15.46M | -338.61%-4.31M | 3.68%-6.07M | 90.18%-1.54M | -128.17%-3.55M | -129.33%-7.55M | 116.00%1.81M | -124.70%-6.3M |
| End cash Position | -87.32%1.9M | -92.01%1.32M | -77.09%4.6M | -77.09%4.6M | -51.22%8.9M | -39.02%14.97M | -58.94%16.51M | -27.35%20.05M | -27.35%20.05M | -53.07%18.25M |
| Free cash flow | 67.20%-2.56M | 39.75%-3.67M | 45.53%-21.66M | 61.63%-3.19M | 27.19%-4.57M | 47.21%-7.81M | 41.32%-6.09M | -5.45%-39.77M | 26.27%-8.32M | 47.82%-6.27M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data